RA
Raolat Abdulai
Internal Medicine
Credentials: · · ·
History
Research
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
New England Journal of Medicine · 2023 · 433 citations
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
New England Journal of Medicine · 2021 · 361 citations
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
New England Journal of Medicine · 2024 · 246 citations
9 papers
8 papers
7 papers
7 papers
- NP
4 papers
- DL
3 papers
- NA
3 papers
- BC
2 papers
